Evidence map›Paper›PMID 19593677›Full record

ArticleCerebellum (London, England)2009

Bergmann glial S100B activates myo-inositol monophosphatase 1 and Co-localizes to purkinje cell vacuoles in SCA1 transgenic mice.

Parminder J S Vig, Qingmei Shao, S H Subramony, Mariper E Lopez, Eshan Safaya

Open access · greenAbstract read
In one paragraph

Article in Cerebellum (London, England), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Intercellular Propagation and Aggregate Seeding of Mutant Ataxin-1.Journal of molecular neuroscience : MN · 2022
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Regulation of autophagy by CaTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Review
  13. Review
  14. Normal cerebellar development in S100B-deficient mice.Cerebellum (London, England) · 2015
    Article
  15. Article
  16. Stabilization and Degradation Mechanisms of Cytoplasmic Ataxin-1.Journal of experimental neuroscience · 2015
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Parminder J S VigDepartment of Neurology, University of Mississippi Medical Center, Jackson, MS 39216, USA. pvig@neurology.umsmed.edu
Qingmei Shao
S H Subramony
Mariper E Lopez
Eshan Safaya
State Street (United States) · USUniversity of Mississippi Medical Center · USJackson Memorial Hospital · US

Funding

Mechanisms of Ataxin-1 Mediated Purkinje Cell DeathR01NS041546 · NINDS · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI VIG, PARMINDER J · 2003 to 2007
$783k
NINDS NIH HHS R01 NS041546
6 · The paper itself

Abstract

Spinocerebellar ataxia-1 (SCA1) is a late onset neurodegenerative disease caused by the expansion of a polyglutamine repeat within ataxin-1 protein. The toxic effects triggered by mutant ataxin-1 result in degeneration of the neurons in cerebellum, brain stem and spinocerebellar tracts. The targeted overexpression of mutant ataxin-1 in cerebellar Purkinje cells (PCs) of the SCA1 transgenic mice results in the formation of cytoplasmic vacuoles in PCs. These vacuoles appear early on before the onset of behavioral abnormalities. Interestingly, we found that vacoules contain S100B and vimentin proteins, which normally localize to neighboring Bergmann glia (BG). Further, immunohistochemical and specialized silver stain analysis revealed that vacuolar formation is associated with alterations in the morphology of dendritic spines of PCs. To gain insights into the mechanisms of vacuolar formation, we investigated if vacuoles in SCA1 PCs have an autophagic origin or are a consequence of some other event. We examined the expression levels (by Western blotting) of microtubule-associated protein light chain 3 (LC3)-I and LC3-II, and the degradation levels of p62 (a LC3 partner) in the cerebellar fractions prepared from pre-symptomatic SCA1 and age-matched wild-type mice. No p62 degradation was observed; however, LC3-II/(LC3-I + LC3-II) ratios were significantly altered in SCA1 mice indicating changes in the autophagic flux. In addition, LC3 localized to PC vacuoles. Further, we observed a co-localization of myo-inositol monophosphatase 1 (IMPA1) with S100B in PC vacuoles. IMPA1 is present in PC spines and has been implicated in autophagy. In vitro studies using purified IMPA1 and S100B demonstrated that S100B interacted with and activated IMPA1. Both apo and Ca(2+)-bound S100B were found to activate IMPA1, depending on substrate concentration. IMPA1 is regulated by another calcium-binding protein calbindin-D28k (CaB), since we reported earlier that the CaB levels are reduced in SCA1 PCs, the activation of IMPA1 by S100B may modulate CaB-dependent inositol signaling. This may cause BG-PC interface to degenerate resulting in vacuolar formation. In sum, these data indicate that vacuoles appearing early in SCA1 PCs could be developing through some unknown autophagic mechanism.

Indexed as

AnimalsAntigens, LyCalbindin 1CalbindinsCells, CulturedCerebellumCytoplasmic VesiclesEnzyme ActivationGene Expression Regulation, EnzymologicGreen Fluorescent ProteinsHumansMembrane ProteinsMiceMice, TransgenicNerve Growth FactorsNeurogliaAntigens, LyCALB1 protein, humanCalb1 protein, mouseCalbindin 1CalbindinsGreen Fluorescent ProteinsLy6a protein, mouseMembrane Proteinsmyo-inositol-1 (or 4)-monophosphataseNerve Growth FactorsPhosphoric Monoester HydrolasesS100B protein, humanS100b protein, mouseS100 Calcium Binding Protein beta SubunitS100 Calcium Binding Protein GS100 ProteinsVimentin

Identifiers

PMID19593677
PMCPMC3351107
OpenAlexW2113413587

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.